Differential Gene Expression in the Prefrontal Cortex and Hippocampus Following Long-Access Methamphetamine...

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Methamphetamine (METH) is a psychostimulant that impairs cognitive and neurobiological functions, particularly in the prefrontal cortex (PFC) and hippocampus.
• Chronic METH use is linked to synaptic plasticity alterations, neuroinflammation, and mitochondrial dysfunction, underlying methamphetamine use disorder (MUD).

Purpose of the Study:

• To investigate gene expression changes in the PFC and hippocampus following long-access intravenous METH self-administration in a rodent model.
• To identify differentially expressed genes (DEGs) and explore correlations between gene expression variability and individual differences in METH demand.

Main Methods:

• RNA sequencing (RNA-Seq) was performed on PFC and hippocampal tissues from METH-treated and control rodents.
• Differential gene expression analysis was conducted to identify DEGs.
• Gene expression patterns were analyzed in relation to measures of METH economic demand.

Main Results:

• 41 DEGs were identified in the PFC and 32 in the hippocampus.
• Downregulation of mitochondrial function genes and upregulation of genes involved in neural development and extracellular matrix organization were observed.
• Distinct molecular profiles, including upregulation of genes like Foxd1 and Cdh1, were associated with higher METH demand in individual rodents.

Conclusions:

• METH exposure induces significant transcriptional changes in brain regions critical for cognition and reward.
• Individual variations in gene expression correlate with differences in drug-seeking behavior, highlighting molecular heterogeneity in MUD.
• Understanding these individual molecular differences may pave the way for personalized therapeutic strategies for MUD.